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Valid data and measurement are central to achieving the Sustainable Development Goal (SDG) aspiration 
of “no-one left behind” [1]. In the United Nation’s Global Strategy for Women’s Children’s and Adoles-
cent’s Health the ongoing imperative for the right to survive, is joined by a new focus on thriving, with 
wider transformation [2]. Progress for survival has been slowest for the 5.5 million deaths of women and 
babies around the time of birth each year, including an estimated 2.5 million newborns dying in the first 
28 days of life, 2.6 million babies stillborn and 303 000 maternal deaths [3-5]. Most of these deaths hap-
pen to the poorest families in the poorest countries, and most are preventable [6]. Opportunity exists to 
save an estimated 3 million lives per year by improving quality of care at birth and care of small and sick 
newborns [7,8]. Based on this evidence, the Every Newborn Action Plan (ENAP) was launched in 2014 
and endorsed by all member states in a World Health Assembly resolution [9]. The plan outlines 2030 
country targets of 12 or fewer newborn deaths per 1000 live births and 12 or fewer stillbirths per 1000 
total births. Every Newborn is closely aligned with the World Health Organization (WHO) Strategy for 
Ending Preventable Maternal Mortality (EPMM) [10] since both include a priority for quality of care at 
birth alongside the Quality, Equity, Dignity movement led by WHO, UNICEF and UNFPA in 11 coun-
tries, aiming to halve facility deaths by 2020 [11].
Accurate data are essential to drive progress towards these targets. However, at the dawn of the SDG era, 
most deaths around the time of birth still occur in settings with the least data on coverage and quality of 
care – the “inverse data law” [12]. One of five strategic objectives of Every Newborn is to transform mea-
surement and use of data to track coverage and quality of care [8,9,13]. A top priority has been to de-
velop and implement a time-limited plan to ensure required core indicators are validated and feasible to 
measure at scale. In support, WHO and the London School of Hygiene & Tropical Medicine (LSHTM) 
have coordinated an ambitious Measurement Improvement Roadmap which reviews specific measure-
ment gaps and provides a multi-year, multi-partner pathway to define specific indicators, test validity if 
needed, develop tools, and promote use of data by 2020 [14-16].
Background To achieve Sustainable Development Goals and Universal Health Coverage, program-
matic data are essential. The Every Newborn Action Plan, agreed by all United Nations member states 
and >80 development partners, includes an ambitious Measurement Improvement Roadmap. Qual-
ity of care at birth is prioritised by both Every Newborn and Ending Preventable Maternal Mortality 
strategies, hence metrics need to advance from health service contact alone, to content of care. As 
facility births increase, monitoring using routine facility data in DHIS2 has potential, yet validation 
research has mainly focussed on maternal recall surveys. The Every Newborn –  Birth Indicators Re-
search Tracking in Hospitals (EN-BIRTH) study aims to validate selected newborn and maternal 
indicators for routine tracking of coverage and quality of facility-based care for use at district, na-
tional and global levels.
Methods EN-BIRTH is an observational study including >20 000 facility births in three countries 
(Tanzania, Bangladesh and Nepal) to validate selected indicators. Direct clinical observation will be 
compared with facility register data and a pre-discharge maternal recall survey for indicators in-
cluding: uterotonic administration, immediate newborn care, neonatal resuscitation and Kangaroo 
mother care. Indicators including neonatal infection management and antenatal corticosteroid ad-
ministration, which cannot be easily observed, will be validated using inpatient records. Trained 
clinical observers in Labour/Delivery ward, Operation theatre, and Kangaroo mother care ward/ar-
eas will collect data using a tablet-based customised data capturing application. Sensitivity will be 
calculated for numerators of all indicators and specificity for those numerators with adequate in-
formation. Other objectives include comparison of denominator options (ie, true target population 
or surrogates) and quality of care analyses, especially regarding intervention timing. Barriers and 
enablers to routine recording and data usage will be assessed by data flow assessments, quantitative 
and qualitative analyses.
Conclusions To our knowledge, this is the first large, multi-country study validating facility-based 
routine data compared to direct observation for maternal and newborn care, designed to provide ev-
idence to inform selection of a core list of indicators recommended for inclusion in national DHIS2. 
Availability and use of such data are fundamental to drive progress towards ending the annual 5.5 
million preventable stillbirths, maternal and newborn deaths.
Validating indicators for coverage and quality of maternal and newborn health care
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Ten core indicators were prioritised as part of the Every Newborn multi-country consultation process in-
cluding those for impact, coverage and input (Figure 1) [9,16,17]. This protocol relates to the coverage 
indicators shown in the middle of Figure 1. Indicators of coverage of care for all women and newborns 
are shaded amber, because whilst definitions are clear, content and quality of care data requires improve-
ment. The greatest metrics gap is core coverage indicators for specific, high impact interventions, shown 
in red in Figure 1. The combination of core indicators for Every Newborn and EPMM is illustrated in Fig-
ure 2 and approximately half of these indicators are the same [10]. Validating the highest priority indi-
cators, highlighted in red in Figure 2, is the topic of this research: all women to receive uterotonics and 
Figure 1. Every Newborn Action Plan core and additional indicators. Shaded – not currently routinely tracked at 
global level. Bold red – indicator requiring additional testing to inform consistent measurement. Asterisk – also 
SDG core or complementary indicator. Indicators disaggregated by equity such as urban/rural, income, and educa-
tion. Adapted from references [9,16,17].
Figure 2. Combined priority indicator table for relevant plans: Ending Preventable Maternal Mortality and Every New-
born [10]. Highlighted in red with box is the priority for measurement improvement and the focus of this research.
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newborns with complications to receive neonatal resuscitation, Kangaroo mother care (KMC), treatment 
for possible serious infections and maternal antenatal corticosteroids (ACS)[16]. The assumed need for 
these interventions, likely coverage and expected prevalence is shown in the Appendix S2, Table S1 in 
Online Supplementary Document.
Coverage is defined as the number of individuals receiving an intervention or service (numerator), from 
among the population in need of the intervention or service (denominator). To date the main source of 
coverage and impact data in high-burden countries has been intermittent household surveys, including: 
Demographic Health Survey (DHS) and Multiple Indicator Cluster Survey (MICS) [18,19]. Current-
ly monitored coverage indicators, including antenatal care, skilled birth attendance and postnatal care, 
mainly measure contact points with health care services but additional indicators are required to capture 
effective content of care [16,20,21]. Quality of care measurement requires definitions of characteristics 
for both provision (eg, safety, effectiveness, timeliness, equity, completeness) and experience of care (eg, 
client satisfaction) [22,23]. Household survey data accuracy depends first on the woman’s interpretation 
of what took place at the time and second on recalling and reporting this understanding up to five years 
after the event. Evidence suggests that household surveys do not always accurately capture either numer-
ator or denominator for some treatment interventions, such as pneumonia in young children [24] and 
events during labour [25]. In addition, since measurement of newborns with complications occur only 
for a subset of births (3%-15%, see Appendix S2, Table S1 in the Online Supplementary Document), 
the sample size required is higher than possible in most national DHS. Consequently, not all desired ma-
ternal and newborn intervention coverage indicators specifically relating to content and quality of care, 
can be captured through household surveys [16,26].
Globally more than 75% of babies are now born in facilities, and local count data from routine registers is 
increasingly available [27]. Whilst health-facility data can be used to track coverage more frequently than 
surveys, previous studies have demonstrated mixed data quality [28-30]. Health workers recording the 
care they deliver face many barriers in documentation [31,32]. Capturing denominators through routine 
data are also a major challenge. Firstly, for indicators regarding interventions for the whole population, 
disaggregated by equity criteria, facility births are not the “true” population denominators. Given the lack 
of specific and appropriate denominator data, a national health management information system (HMIS) 
typically use census-based data for deriving forecasts and key population calculations [28]. Secondly, the 
challenge is magnified if the “true” denominator for the intervention is based on clinical need, so target-
ed at a proportion of the total population eg, requiring treatment for possible serious bacterial infection. 
Measurement of the “true” denominator requires consistent and objective measure of clinical need. Yet 
clinical judgement and decision making, even using evidence based algorithms, is often still subjective 
[33,34]. Live births are often used as a proxy denominator when it is challenging to define and measure 
the “true” denominator. A benchmark “target coverage level” is required when proxy denominators are 
used, because 100% coverage is only a target for a “true” denominator. For example, the “true” denom-
inator for Caesarean Section rate is “women in need for Caesarean section”. Because this is challenging 
to define and measure, the proxy denominator per 100 live births is used, but benchmarking a “target 
Caesarean Section rate” has proved complex [35-39]. Large inequity within countries and over- and un-
der-provision occurring in parallel [40] highlight the problem of constructing useful indicators to measure 
and compare met need for complications. Therefore, an important focus of this study will be to compare 
various denominator options and, if using a proxy denominator to consider benchmarking.
The hierarchy of data needs (Figure 3) illustrates scope and granularity of data use decreases at higher 
levels of the health system [41]. At the point of service delivery, data are needed for individual clinical de-
cisions and to measure the client’s perspective of care received. At facility level, aggregate data are collated 
to inform administrative and managerial decisions for planning and local quality improvement, mortal-
ity audit etc. At district level, data are required for planning (eg, human resources, equipment and drug 
availability). At national and global level, it is not possible or useful to collate all these data used at lower 
levels of the system. But it is crucial for accountability purposes to track a few core, standardised indica-
tors to monitor SDGs and Universal Health Coverage at all levels – these “core indicators” are shown in 
the centre of the pyramid (Figure 3). WHO maintains a core list of 100 health indicators [42] and ENAP 
has prioritised 10 core indicators [9,16,17].
Improvements in civil and vital registration systems are enabling a more rapid transition to more timely 
denominator data on births and deaths. Data systems are transitioning to increasing use of HMIS to col-
lect, collate, analyse and report routine data from health facilities up to district and national level. This 
has potential to be cost-efficient and generate more frequent coverage measurements [16,27]. Electronic 
Validating indicators for coverage and quality of maternal and newborn health care
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HMIS platforms are increasingly being applied, offering great potential to harmonize traditionally frag-
mented information streams [43]. One such platform, the District Health Information System, version 2 
(DHIS2) [44] is now being successfully implemented in >50 countries with high mortality burdens. In-
frastructure and software development advances are currently driving a transition from predominately 
paper-based to mixed recording systems, even at clinical data level, ie, electronic patient records will in-
creasingly be the basis of HMIS data in low-middle income country (LMIC) contexts.
Testing indicator validity is critical to improve measurement and inform decision makers of the likely 
accuracy of coverage collected by household survey and/or routine facility data [20]. Comparison of the 
reported indicator to an external data source “gold standard” is recommended [45]. Previous validation 
studies have mainly focused on population-based intervention coverage indicators for use in household 
surveys [25,46-48]. Observational studies to determine accuracy of facility registers in high burden set-
tings have typically focused on outcome indicators [29]. The EN-BIRTH study seeks to address current 
evidence gaps by testing validity of priority coverage indicators for newborn and maternal health, in fa-
cilities in three high burden country settings.
Aim
This paper is the protocol paper for the Every Newborn-Birth Indicators Research Tracking in Hospitals 
(EN-BIRTH) Study, which aims to test validity of selected newborn and maternal care health intervention 
indicators (coverage/ quality aspects and/or safety) in facilities (Table 1). This study, as part of the Every 
Newborn Measurement Improvement Roadmap, and working closely with EPMM, aims to increase the 
evidence base to inform selection and use of maternal and newborn indicators in national HMIS (partic-
ularly DHIS2), and global tracking.
Research objectives
The research questions per objective, methods and analysis are detailed in Table 2.
Objective 1 – Numerators: To determine validity (accuracy) of both routine facility register and mater-
nal recall surveys, compared to direct observation for selected maternal and newborn care interventions: 
uterotonics for 3rd stage labour, immediate breastfeeding, neonatal resuscitation, KMC; and, verification 
with patient case notes: neonatal infection management, and ACS administration (Table 1).
Objective 2 – Denominators: To compare different denominator options including proxies, and assess 
feasibility of their use in routine data platforms (Table 1), including:
• Target population requiring intervention (clinical need) in the facility (“true” denominator)
• Live births in the facility
• Total births (live births and stillbirths) in the facility
• Estimated population births (live or total): facility births and home births
Figure 3. Data collection and use by level of health system. Adapted from [41].
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Table 1. EN-BIRTH study selected indicators to be assessed for validity
IndIcator Place of care numerator denomInator oPtIons
Uterotonic use for 3rd 
stage of labour
Labour/Delivery ward, or 
operating Theatre
Number of women who received a uterotonic 
immediately after birth
-  Per 100 live births (currently used denom-
inator)
- Per 100 total births
Immediate newborn care Number of babies who breastfed immediately 
after birth as possible surrogate for immediate 
newborn care
Per 100 live births (currently used denom-
inator)
Number of newborns who had chlorhexidine 
applied to the cord stump after birth (Bangla-
desh and Nepal only)
Newborn resuscitation Number of newborns for whom resuscitation 
actions (Bag and Mask Ventilation) were ini-
tiated
To be compared for all 4 denominators 
options:
-  Target population requiring the specific in-
tervention (eg, admitted to the facility with 
presumed infection or at risk of preterm 
birth as per WHO guideline)
- Live births in the facility
-  Total births in the facility (including still-
births)
-  Estimated births in the population (live or 
total)
Kangaroo mother care 
(KMC)
KMC ward/ area Number of eligible (<2000g) newborns initi-
ated on facility-based KMC
Treatment of neonatal  
infection
Newborn or postnatal 
wards
Number of neonates (<28 days old) who re-
ceived at least one dose of antibiotic injection*
Antenatal corticosteroid 
(ACS) use
Labour/delivery ward or 
antenatal ward
All women giving birth in a facility who are 
24-34 weeks and received at least one dose 
of ACS†
*Specific exclusions apply to exclude other primary diagnoses eg, congenital abnormalities, preterm births <32 weeks or <1500g and neonatal en-
cephalopathy.
†ACS focus is to track safety, test methods to include gestational age and relevant safety outcomes.
Table 2. EN-BIRTH study summary of research questions, data collection and analysis by objective
research questIons data collectIon method data analysIs aPProach
Objective 1 – Numerators
-  Do registers give a valid representation of observed 
maternal and newborn interventions?
-  Do maternal recall survey questions used in house-
hold surveys capture a valid representation of the 
observed maternal and newborn interventions?
- What is the consistency between observers?
-  Observation of clinical practice (or verification 
from inpatient records for neonatal infections and 
ACS) plus video film for neonatal resuscitation 
(Nepal only)
- Maternal recall survey (all six indicators)
- Extraction from routine data sources
- Sensitivity, positive predictive value
-  Specificity of numerator for those with all 
birth denominator or clearly measurable 
denominator 
- Inter-rater reliability (Cohen’s Kappa)
Objective 2 – Denominators
-  How different are the coverage estimates when us-
ing alternative denominator options?
- Which denominator options are feasible for use in 
each country HMIS?
Observation of clinical practice for measurement of 
“true” denominator
Collection of hospital documentation for the de-
nominator or alternative denominator options
- Descriptive statistics
-  Quantitative analysis with inflation factor 
for indicators with all-birth denominator
Objective 3 – Content and quality of care
-  What content of care are women and newborns 
observed to receive for each intervention, with fo-
cus on timing?
-  Which aspects of the content of care are already 
accurately recorded in registers?
-  Which aspects of the content of care are accurately 
recalled by women?
Observation of clinical practice (or verification from 
inpatient records for neonatal infections and ACS) 
plus video film for neonatal resuscitation (Nepal 
only)
Maternal recall survey (all six indicators)
Extraction from routine data sources
-  Assessment of content/quality of care for 
specific aspects related to each interven-
tion with emphasis on timing
Objective 4 – Barriers and enablers
-  Are some indicators recorded more completely 
than others? 
-  Has routine recording changed during the time of 
the study? 
-  What are the barriers and enablers to measurement 
of these indicators? 
-  What are the barriers and enablers to perceived use 
of data regarding these indicators? 
-  How can facility recording and flow of informa-
tion into DHIS2 for these indicators be improved? 
Quantitative – Register review for 12 months before 
and during study
Qualitative FGD/IDI of study data collectors 
Qualitative FGD/IDI of health workers 
Qualitative FGD/IDI of other data users (policymak-
ers etc) regarding data utility
Process evaluation of data flow from patient lev-
el to DHIS2 
-  Quantitative comparison of registers ap-
plying data quality scores comparing be-
fore and after 
-  Qualitative data for data collectors, health 
workers and data users
-  Process evaluation of data flow to DHIS2
FGD – focus group discussion, IDI – in-depth interview, DHIS2 – District Health Information System 2
Validating indicators for coverage and quality of maternal and newborn health care
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Objective 3 – Content /quality of care: To evaluate different domains of coverage (eg, timing, comple-
tion rates, safety) for selected interventions (Table 3).
Objective 4 – Barriers and enablers: To evaluate barriers and enablers to routine recording of selected 
indicators, and to explore perceived utility of these data to improve decision-making, coverage and qual-
ity of care at all levels.
Table 3. EN-BIRTH study – Examples of indicator quality of care research questions, particularly regarding timing
InterventIon research questIon to answer usIng observatIon data
Uterotonic Proportion of mothers who received oxytocin within recommended one minute after birth
Immediate breastfeeding Proportion of babies whose breastfeeding was initiated within one hour of birth
Resuscitation Proportion of non-breathing babies who had bag-and-mask initiated within one minute of birth
Kangaroo mother care Proportion of babies receiving KMC, held in skin-to-skin position for 18 h or more, during the last 24 h
Neonatal infection Proportion of cases with presumed sepsis, treated with antibiotics and for whom a blood culture result was available
Antenatal corticosteroids Proportion of preterm labour cases who received antenatal corticosteroids according to WHO criteria for safety
METHODS
Study design
The EN-BIRTH study uses quantitative and qualitative methods across four objectives (Table 2). The 
validity of coverage indicators of selected maternal and newborn interventions as measured by routine 
facility registers and maternal recall surveys will be assessed by comparison with the “gold standard” of 
direct observation (Figure 4, panel A). Observation will be undertaken in three clinical settings (labour/
A
B
Figure 4. EN-BIRTH study validation and analysis approach. Panel A. Validation “gold standard” comparison to 
routine data (eg, HMIS/DHIS2) and to maternal recall survey data (eg, for household surveys). Panel B. Analysis 
for validation of sensitivity and specificity. Asterisk – recorded in facility L&D or KMC register / reported in mater-
nal recall survey.
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delivery ward, operation theatre, and KMC ward/area) by trained clinical observers. Data will be extract-
ed from facility registers and verification of inpatient records carried out for newborns who received an-
tibiotics for presumed infection, and for women who received ACS. Interviews to capture maternal recall 
will be conducted prior to discharge with all women whose births and/or their newborn’s care were ob-
served or case notes were verified. In addition, barriers and enablers to recording of selected indicators 
in routine facility registers will be evaluated. Data flow into national HMIS platforms and perceived util-
ity of data will be documented.
Research questions were informed by consultation with many Every Newborn stakeholders [9,17] includ-
ing WHO-led Measurement Improvement Roadmap meeting [15] and EN-BIRTH Expert Advisory Group 
(listed as author group). More than 60 participants in an EN-BIRTH study design workshop [49] pro-
vided representation from country partners, national stakeholders, UN agencies, leading academic and 
professional experts in the field, governmental and non-governmental organisations, clinicians, program 
managers, other key experts and donors (see Appendix S1 in Online Supplementary Document) and 
contributed to development of the research protocol (Box 1).
Box 1. Authorship teams for EN-BIRTH study
EN-BIRTH LSHTM Team: Louise T Day, Harriet Ruysen, Vladimir S Gordeev, Georgia R Gore-Langton, Dor-
othy Boggs, Simon Cousens, Sarah G Moxon, Hannah Blencowe, Angela Baschieri.
EN-BIRTH Co-PI and country teams
Bangladesh: Ahmed Ehsanur Rahman, Tazeen Tahsina, Sojib Bin Zaman, Tanvir Hossain, Qazi Sadeq-ur Rah-
man, Shafiqul Ameen, Shams El Arifeen.
Nepal: Ashish KC, Shree Krishna Shrestha, Naresh P KC, Dela Singh, Anjani Kumar Jha,
Bijay Jha, Nisha Rana, Omkar Basnet, Elisha Joshi, Asmita Paudel, Parashu Ram Shrestha, Deepak Jha, Ram 
Chandra Bastola, Jagat Jeevan Ghimire, Rajendra Paudel.
Tanzania: Nahya Salim, Donat Shamba, Karim Manji, Josephine Shabani, Kizito Shirima, Namala Mkopi, Mwi-
fadhi Mrisho, Fatuma Manzi, Jennie Jaribu, Edward Kija, Evelyne Assenga, Rodrick Kisenge, Andrea Pembe, 
Claudia Hanson, Godfrey Mbaruku, Honorati Masanja. 
Senior author/corresponding:  Joy E Lawn
With the EN-BIRTH Expert Advisory group
Agbessi Amouzou, Tariq Azim, Debra Jackson, Theopista John Kabuteni, Matthews Mathai, Jean-Pierre Monet, Al-
lisyn Moran, Pavani Ram, Barbara Rawlins, Johan Ivar Sæbø, Florina Serbanescu, Lara Vaz, Nabila Zaka.
On behalf of the EN-BIRTH study research design Windsor Workshop Invitees (not already names in above 
author groups
AI Ayede, Simon Azariah, Anne-Marie Bergh, Elahi Chowdhury, Olive Cocoman, Patricia Coffey, Jai Das, Ashok 
Deorari, Mary Drake, Queen Dube, Suzanne Fournier, John Grove, Rima Jolivet, Amira Khan, Dyson Likom-
wa, James Litch, Goldy Mazia, Kate Milner, Indira Narayanan, Susan Niermeyer, Alfred Osoti, Sayed Rubayet, 
Joanna Schellenberg, Wilfred Senyoni, Gaurav Sharma, Kavita Singh, Nalini Singhal, Cally Tann, Steve Wall.
Study settings
Tanzania, Bangladesh and Nepal were chosen as LMIC’s currently implementing the selected maternal and 
newborn interventions within Sub-Saharan Africa and Asia [50]. Within these countries, research centres 
of excellence with a strong track record in maternal and newborn health were selected: Ifakara Health 
Institute (IHI) and Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania, Interna-
tional Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b); UNICEF-Nepal with Lifeline in Ne-
pal. Criteria for selection of facilities were: providing the selected interventions in line with current WHO 
recommendations for improving quality of care; existing registers recording most interventions; and suffi-
cient number of births to ensure sample size (except for ACS discussed under sample size section below).
Study populations
Inclusion / exclusion criteria for consenting women according to data collection methods (Figure 5) are:
•  Observation on labour and delivery, operating theatre: All admitted women in active labour 
excluding those likely to deliver immediately. Women with a prior diagnosis of intrauterine death, 
were also excluded to avoid further maternal distress.
Validating indicators for coverage and quality of maternal and newborn health care
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• Observation KMC ward/area: All in-born and out-born neonates admitted for KMC.
•  Verification from inpatient records for ACS administration: All women being observed and re-
ported to be <34 weeks’ gestation at admission from Expected Date of Delivery (EDD).
•  Verification from inpatient records for neonatal infection cases: All babies < 28 days old with 
a main diagnosis of infection (sepsis/meningitis) recorded in neonatal register or admission/dis-
charge book. Babies will be excluded for major congenital abnormality, neonatal encephalopathy/
severe asphyxia, <32 weeks’ gestation and/or admission weight <1500 grammes.
•  Maternal recall survey: All women whose birth and/or their newborn’s KMC will be observed, or 
case notes verified for ACS or neonatal infection.
• Routine register extraction: All women whose birth and/or their newborn’s KMC will be observed.
Sample size
Sample size was based on planned analysis for validity in objective one, by assuming 50% sensitivity 
±10% precision, 50% specificity ±10% precision, with α = 0.05 and then applying the lowest previously 
published rates for neonatal resuscitation [51] and for KMC initiation [52,53]. Since formative data sug-
gested >80% coverage for uterotonic administration, this indicator will be well-powered (see Appendix 
S2, Tables S2-3 in Online Supplementary Document). Hence minimal sample size is 4850 observa-
tions in each country, increased to 5390 observations to allow for a non-consent rate of 10% (Table 4). 
As expected prevalence of ACS is less than 0.5%, the resulting very large sample size was not feasible for 
this study [54,55]. The 5390 observations will be collected from three countries. In Tanzania and Nepal, 
each facility will observe this number of births, and in Bangladesh observations will take place in two fa-
cilities (Table 4) [4,5,56]. We anticipate a total >20 000 observed births aiming to capture at least 106 
observations per intervention per country, except for ACS (Table 4 and Appendix S2, Table S3 in Online 
Supplementary Document).
Tool development
A formative research phase was undertaken from July – December 2016 including: health facility assess-
ments [57], register reviews, data flow assessments, and interviews/focus group discussions (FGDs) with 
women, caregivers, health workers and senior facility-level staff. The results helped ensure study sites 
could meet inclusion criteria, achieve required sample size and informed refinement of observer check-
lists and data collection processes. Maternal Recall survey tools were translated into local languages and 
back-translated.
Table 4. EN-BIRTH study – national mortality rates, facility context and expected number of births and cases per indicator
context facIlItIes samPle sIze
Country National mortality 
rates*
Name Hospital type Annu-
al total 
births
Expected 
births in 
study
Uteroton-
ic use†
Each for: resuscitation, Kan-
garoo mother care, neonatal 
infection management†
Tanzania MMR = 398 /100 000 
NMR = 22/1000 
SBR = 22/1000
Muhimbili National Hos-
pital, Dar es Salaam
National Refer-
ral & Universi-
ty Teaching
9773 5390 >4310 >106
Temeke Regional Hospi-
tal, Dar es Salaam
Regional  
Referral
14 655 5390 >4310 >106
Subtotal 10780 >8620 >212
Bangladesh MMR = 176/100 000 
NMR = 21/1000 
SBR = 25/1000
Maternal and Child 
Health Training Institute 
(MCHTI), Dhaka
Tertiary 4488 2695 >2150 >53
Kushtia District Hospital Secondary 2581 2695 >2,150 >53
Subtotal 5390 >4,310 >106
Nepal MMR = 258 /100 000 
NMR = 22/1000 
SBR = 18/1000
Pokhara Academy of 
Health Sciences
Tertiary 9427 5390 >4310 >106
TOTAL all 40 924 21 560 >17 240 >424
*MMR – maternal mortality ratio per 100 000 live births [5]; NMR – neonatal mortality rate per 1000 live births [54]; SBR – stillbirth rate per 1000 
total births [4].
†Prevalence/incidence based on references [51-53,55,56]. More details in Appendix S2 of Online Supplementary Document.
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Data collection software application
The development of a customised tablet-based software application (Android-based) for data collection 
and monitoring was undertaken by the icddr,b team supported by LSHTM (Figure 5 and Figure 6) [58]. 
The software application has different permissions for various data collector cadres (observation, veri-
fication, maternal recall survey, and data extraction) and translated into local languages where relevant. 
Time-stamped data will be collected using this EN-BIRTH data collection software, stored locally on the 
tablet, and synchronised regularly to the local central secure database server.
Training of data collectors and supervisors
Data collector cadres include: tracker (responsible for consent, registration and assigning for observa-
tion/record verification and subsequent tracking); observer (direct observational data for assigned wom-
en and babies); interviewer (maternal recall survey interviews); data verifier/extractor (data from facility 
registers or case notes); and supervisor (responsible for all data collectors and quality assurance) (Figure 
5). Observers with a clinical background (eg, nurses) will be recruited. Data collection staff will receive 
two weeks of training using classroom-based sessions, group activities and mock data collection within 
the health facility, detailed in the Data Collectors Training Handbook [58]. Observer training will include 
guidance on response to specific events, including managing maternal distress and when to pause data 
collection and assist in the care of the patient, if they perceive facility staff are responding inappropriately 
to a life-threatening situation. A minimum individual post-training assessment score of ≥80% is required 
before data collection can commence.
Procedures according to data collection method
Observation (Objectives 1, 2, and 3)
Informed written consent will be obtained prior to study registration and basic demographic data collected 
(Figure 5) by the tracker. Verbal consent will be obtained from the health workers. Observers working in 
Labour/Delivery ward, Operating theatre and KMC ward/areas will collect direct clinical observation data. 
These observers will not interact with participating pregnant women, her family members or attending 
health workers during observation (except to respond to a life-threatening event [58]).
Observations on Labour/Delivery ward will focus on specific aspects of: 1st, 2nd and 3rd stage of labour, 
postpartum haemorrhage, immediate newborn care and neonatal resuscitation. Multiple parameters will 
be recorded to assess content/quality of care, particularly related to intervention timing. KMC observa-
tions will focus on domains of initiation, position, feeding and other treatment administered. Mother and 
baby outcome at discharge from hospital will be documented [58].
Figure 5. EN-BIRTH study – overview of data flow in study sites. Data Collection – “ward registers” on one line. Data col-
lector roles revised with “Data Verifier” added. Data Systems needed “web based database” (word database was missing). 
ACS – antenatal corticosteroids.
Validating indicators for coverage and quality of maternal and newborn health care
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Additionally in Nepal for neonatal resuscitation, observation video film recording and physiological as-
sessment will be undertaken. Information regarding these additional processes will be provided separately 
to women and informed, signed consent taken [59]. Video cameras and pulse oximeters will be placed on 
resuscitation tables within Labour/Delivery ward and Operating theatres and research staff trained in this 
equipment operation and maintenance. A trained data collector will complete the observation checklist 
for resuscitation using the recorded video within 24 hours of birth [60,61]. If consent is subsequently 
withdrawn for video use, this data will be excluded, and the video deleted.
Verification using inpatient notes (Objectives 1, 2, and 3)
During the formative phase it was recognised that direct observation was not feasible for two of the se-
lected interventions (neonatal infection and antenatal corticosteroids). For these interventions, data ver-
ifiers will use patient charts/ case notes, drug charts, laboratory reports and other relevant routine docu-
mentation to verify intervention and quality of care measurements. Supervisors will review/search for any 
missing or illegible documents before confirming data not readable/ not recorded [58].
Maternal Recall Survey (Objectives 1, 2, and 3)
Data collectors will interview mothers whose baby’s birth or treatment is observed and/or verified prior to 
discharge from postnatal or KMC ward/areas The software programming of the structured questionnaires 
will automatically skip certain questions to minimise any risk of further emotional trauma if the mother 
has experienced a stillborn or neonatal death [58]. For multiple births the interview will be completed 
only for first-born babies. Consent will be repeated before this interview in recognition that the moth-
er may have been in labour when she first consented to participation in this research. Consent will also 
be taken for repeat maternal recall surveys at different intervals after discharge, if funded for follow-up.
Routine register data extraction (Objectives 1, 2 and 3)
Data extractors will use routine labour/delivery registers, KMC registers and neonatal ward registers to 
extract participant data recorded by facility staff. If data are illegible or cannot be found, supervisors will 
review/search for these documents, before documenting data not readable/not recorded [58].
Assess barriers and enablers (Objective 4)
Mixed methods will be used to identify barriers and enablers to routine data recording and use of select-
ed indicators (Table 1). Completeness and quality of existing documentation in routine registers (labour/
delivery, KMC and/or neonatal) for 12 months prior to the study will be evaluated. In Bangladesh and 
Nepal, 100% of cases in these registers will be extracted. In the Tanzanian facilities, with a high number 
of births, a 20% sample randomly selected will be used for labour/delivery cases with 100% for KMC 
and neonatal infection cases.
Figure 6. EN-BIRTH study software data collection showing examples of the tablet application screen shots.
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Qualitative data collection tools for FGD, in-depth and key informant interviews will be informed by 
the MEASURE Evaluation Performance of Routine Information System Management (PRISM) conceptu-
al framework and tools [62], including constructs for Technical, Organizational and Behavioural factors. 
Data will be collected from study data collectors and facility health workers. Data flow assessments will 
provide information on movement of data from registers, into DHIS2 and up to national level. Addition-
ally, perceptions regarding indicators which are considered most valuable and most feasible to collect will 
be explored through interviews with policy makers and technical managers of DHIS2.
Data quality monitoring
The EN-BIRTH data collection software includes skip rules, and consistency checks as well as pre-defined 
value ranges for some variables. Progress will be monitored by an online data dashboard, providing re-
al-time summary tables per site, including data capture cascade for selected coverage indicators at each 
step; registration, consent, observation/ verification, maternal recall survey and register data extraction. A 
traffic light system will indicate overall progress for each indicator using pre-defined thresholds. Bi-week-
ly all-site calls will provide an opportunity for country teams to review and discuss progress using these 
data dashboards, in addition to promoting collaborative quality improvement initiatives between coun-
tries and sites.
As part of the quality assurance process, for approximately 5% of cases in each site, simultaneous super-
visor observation and duplicate data verification and extraction will also be conducted using EN-BIRTH 
data collection software. The supervisor data will be regarded as the standard, stored in a separate data-
base, and variability between individual data collectors estimated by calculating inter-rater reliability us-
ing Cohen’s kappa (κ) coefficient. Minimum agreement levels of ≥71% for observation and ≥91% for data 
extraction/case verification will be used [63].
Data management
EN-BIRTH tablet data will be synchronised, and uploaded to an in-country central server, regularly 
backed-up. Raw data will be encrypted, and access restricted to country data manager who will anony-
mise data before data sets are pooled. Server maintenance, data management, and cleaning will be co-
ordinated according to agreed protocols including logical and completeness checks. A unified variable 
code book will contain description of variable names and answer options. Qualitative data will be dig-
itally recorded, transcribed, and translated into English. All data will be stored on password-protected 
computers.
Analysis plan
Analyses will be coordinated, using a standard approach, both combining sites, and with site-specific and/
or country-specific analyses. An overview of research objectives, main research questions and data anal-
ysis approach are summarised in Table 2. Quantitative analyses will be undertaken with Stata 15 (Stata 
Statistical Software: Release 15).
Objective 1 – Numerator
The “gold standard” used for comparison will be direct observation of selected interventions by research 
observer, except for neonatal infection and ACS, where in-patient note verification will be used. Data ex-
tracted from facility routine register records and data collected during maternal recall survey will be com-
pared with this “gold standard” separately (Figure 4, panel A). Accuracy of each individual coverage indi-
cator will be assessed by constructing two-by-two tables to analyse the sensitivity and positive-predictive 
value of routine data (Figure 4, panel B). Specificity of routine data will be assessed for those indicators 
with true negatives and confidence intervals will be computed. “Area Under the Curve” previously used 
for coverage indicators validation will be used for indicators with true negatives [25,46-48,64].
Objective 2 – Denominators
Various denominator options (Table 1) will be compared using descriptive statistics to assess variation in 
estimated coverage and undertake analyses to guide benchmarking. Information on denominators will 
come from the EN-BIRTH data set, facility total birth data collected from facility reports, and population 
birth data from estimates based on census or survey and fertility rates, as used in DHIS2. For indicators 
with a whole population denominator (ie, uterotonics, breastfeeding) or a clearly measurable “true” de-
Validating indicators for coverage and quality of maternal and newborn health care
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nominator regarding clinical need (eg, KMC – birth weight <2000g), the inflation factor will be used. 
Inflation factor is the ratio of estimated routine recording-based prevalence to true (observed) popula-
tion-based prevalence. It represents the magnitude of over- or under-estimation in the study setting rel-
ative to true population-based prevalence.
Objective 3 – Content/quality of care
Multiple recorded parameters will be analysed to assess measurement related to content/quality of care, par-
ticularly regarding timing of interventions and in relation to WHO Guideline recommendations (Table 3).
Objective 4 – Barriers and enablers
To assess barriers and enablers to indicator data recording and use, mixed methods will be used based on 
a framework adapted from PRISM [62] and considering other tools [65]. Quantitative analysis of routine 
register data collected prior to and during the study will address two research questions: (1) Are some 
indicators recorded more completely than others? (2) Has routine recording changed during the study 
time? Qualitative data from FGDs, in-depth and key informant interviews will be analysed using QSR In-
ternational’s NVivo 12 qualitative software (NVivo qualitative data analysis Software; QSR International 
Pty Ltd Version 12.1, 2018). Predetermined codes will be applied by two independent researchers, data 
managed into units of information covering broad categories with grouping of relevant emerging themes 
of importance.
DISCUSSION
EN-BIRTH is the first large study to assess validity of newborn and maternal care indicators in routine 
data systems, doing so at very large scale (>20 000 observed births) across three countries with a high-bur-
den of mortality. Previous maternal and newborn indicator validation studies have focused on testing 
the validity of women’s self-report method, used in population-based household surveys [25,46-48,64]. 
Validation of facility registers have focussed on outcome measures [29]. The EN-BIRTH study seeks to 
validate both routine registers and maternal recall at discharge for coverage indicators of high impact in-
terventions. The novel software developed for this research allows detailed and precise recording of events 
around the time of birth, and particularly the timing of interventions. There are many studies examin-
ing quality of care at birth [66,67], and this research is not repeating that, but is focused on accuracy of 
routine reporting of care.
This research responds to calls from country and programme leaders for guidance on indicators for ma-
ternal and newborn services, tracking progress towards meeting national targets and Universal Health 
Coverage [9,17,68]. The high reporting load for many countries with multiple programmes, donors, and 
indicators, may result in the so-called data rich, information poor (DRIP) syndrome [69]. In addition to 
high reporting burden on the system, the individual midwives and doctors are responsible for recording 
data in multiple registers and patient records, sometimes at the expense of providing respectful quality care 
for women and babies. Hence a shorter list of evidence-based, indicators is required for national tracking, 
taking in to account validity and utility in low-resource, high-burden settings. The results of this study 
will inform recommendations for indicators appropriate for uptake within HMIS, and may also identify 
some that are not appropriate for use at higher levels of the health system (Figure 3). This research will 
also help inform improved capture and quality of data in HMIS, and especially DHIS2.
During the MDG-era, population-level surveys were the most common data source in high-burden coun-
tries, but studies consistently demonstrate challenges with maternal recall data, especially regarding de-
tails of clinical interventions [24,25,46,47,64]. For data that require medical knowledge and especially 
events that women may not have closely witnessed (eg, neonatal resuscitation), we expect poor mater-
nal recall, which may reflect the lack of information given to families experiencing complications. Given 
continued reliance on household surveys for demographic and health data in many remote or unstable 
settings, we anticipate the main value of our maternal recall survey validation findings will be to contrib-
ute to the understanding of which indicators are not suitable for use in household surveys. We anticipate 
that if the woman does not know about the intervention at discharge from hospital, then recall later will 
not be useful.
A strength of this study design is the rigorous assessment of validity at scale, of facility routine data by 
comparison with direct observation, defined here as the “gold standard”. Another strength is a specific fo-
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cus on the denominator challenge. In an era of Universal Health Coverage, with discussions surrounding 
scale-up of more complex care for targeted populations, the science of denominator measurement, use 
of proxies, and selection of benchmarks will be increasingly important. This challenge applies to denom-
inator measurement for maternal and newborn complications (as well as other large burden conditions, 
notably non-communicable diseases). This study, however, is not designed to validate the denominator 
based on subjective assessment of clinical need (eg, requiring neonatal resuscitation). Hence, we will only 
be able to measure true negatives, calculate specificity, and undertake analysis of “area under the curve” 
for interventions with a total population or clearly defined denominator [25,46-48,64].
This research also offers a unique opportunity to examine quality of care data from >20 000 births and 
assess to what extent we can accurately capture specific components including content and timing of se-
lected interventions. Although multiple specific aspects of care may be measured locally to drive quality 
of care improvement at facility level, here we will focus on quality of care indicators that may be useful 
at district or national levels of the health system. Timing of interventions is a critical marker of quality 
of care, since delays are a matter of life or death: a woman may die in hours, a baby in minutes. More-
over, the sequence of interventions is complex and even concurrent (eg, how often is the correct dose of 
uterotonic given <1 minute after birth to prevent a woman bleeding from postpartum haemorrhage; How 
soon is bag-and-mask ventilation initiated for a baby who is not breathing; How many hours each day is 
a baby kept in KMC position). The time-stamped design of EN-BIRTH data collection software will per-
mit analysis of such sequences.
Whilst direct observation is considered the “gold standard”, data collectors might miss interventions, 
with concurrent actions at birth, especially in an emergency. We will limit potential recording bias by us-
ing observers with health backgrounds who are familiar with the procedures under observation [70-72]. 
EN-BIRTH data will also be directly on the tablet software to allow fast data capture. The study also pres-
ents several ethical challenges including the dilemma of observing a life-threatening situation without 
appropriate response from facility staff, and gaining informed consent during labour [58]. The clinically 
trained observers will have underlying familiarity of hospital environments, experience to uphold study 
protocols correctly [70] and experience in maintaining participant confidentiality. Training and processes 
will be put in place to take account of professional and legal duty of care.
The “Hawthorne effect” describes the phenomenon when a research participant’s behavior is altered as 
a consequence of being studied or observed, and can be a source of bias in observational research [73]. 
Within this study, it is possible that clinical observers’ presence will influence health workers to change 
their approach to care and routine register data. However, there is some evidence to suggest that sus-
tained contact with participants (as with this study) may mitigate altered behaviors in health care set-
tings [74]. To assess this bias, we will analyze changes in register data completeness and quality before 
and during the study.
Although the EN-BIRTH study is not powered to validate an ACS administration indicator, this will be 
included. Current WHO guidelines provide strong recommendation for the provision of a single course 
of ACS for any woman at risk of imminent preterm birth (24-34 weeks of gestation) provided the follow-
ing criteria are met: 1) accurate assessment of gestational age; 2) no evidence of maternal infection; 3) 
preterm birth is considered imminent; 4) available adequate childbirth and newborn care services [75]. 
EN-BIRTH study sites were assessed in accordance with these WHO guidelines. The Antenatal Cortico-
steroid Trial (ACT) evaluated use of ACS at lower levels of the health system, with half of study births 
in home settings and care often provided by traditional birth attendants [76]. ACT reported an adverse 
outcome risk particularly in cases where ACS administration was after 34 weeks and outlines important 
challenges for measurement of gestational age, and assessment of maternal infection. This demonstrated 
need for robust data and further evidence in such settings, along with the imperative of ensuring safety 
and effectiveness, make measurement of ACS coverage and outcomes essential. Therefore, the EN-BIRTH 
study ACS analysis will focus on assessing relevant documentation to report the current ACS administra-
tion practice, compared with WHO safety criteria [75].
Given the importance of the neonatal period in terms of risk and prevention of long-term adverse child 
development outcomes, we plan a five-year follow-up for EN-BIRTH study recruited children who re-
ceived basic neonatal interventions [77]. The Every Newborn – Simplified Measurement Integrating Lon-
gitudinal Neurodevelopment & Growth (EN-SMILING) aims to detect child development outcomes as 
early as possible for referral to services, and to improve routine measurement of child development out-
comes in programme settings.
Validating indicators for coverage and quality of maternal and newborn health care
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The EN-BIRTH study is richer through active involvement of experts and policymakers from the EN-
BIRTH Expert Advisory Group, Every Newborn implementation community, EPMM, UN Agencies includ-
ing WHO, UNICEF and UNFPA as well as many partners and donors. In further support of this goal, 
each of the three countries have National Advisory Committees who will actively participate in the re-
search process and support uptake of findings. Results will also be published in peer reviewed journals 
and disseminated with all relevant audiences. Following EN-BIRTH study validity testing, an important 
next step will be to evaluate feasibility of a short-list of indicators at different levels of the health system.
Most of the 5.5 million deaths around the time of birth [3] still occur in settings with the least data. House-
hold surveys remain a key data source in the poorest countries, and Every Newborn is also involved in a 
multi-site study, EN-INDEPTH, to assess and improve these data [78]. Data improvement is fundamental 
for monitoring more rapid progress towards meeting global and national mortality targets, and in achiev-
ing Universal Health Coverage for all women and newborns [15]. With ongoing investment in electronic 
data platforms (including DHIS2) and increasing country demand for evidence-based indicators, we an-
ticipate that these results will advance availability and use of data to change coverage, quality and equity, 
to help end preventable maternal and newborn mortality, as well as stillbirths.
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